Literature DB >> 7854527

Mitochondrial encephalomyopathy associated with a single nucleotide pair deletion in the mitochondrial tRNALeu(UUR) gene.

J M Shoffner1, M G Bialer, S G Pavlakis, M Lott, A Kaufman, J Dixon, S Teichberg, D C Wallace.   

Abstract

The investigation of pathogenic mitochondrial DNA (mtDNA) mutations has revealed a complex relation between patient genotype and phenotype. For unknown reasons, some mtDNA mutations produce specific clinical manifestations such as chronic progressive external ophthalmoplegia; myoclonic epilepsy and ragged-red fiber disease (MERRF); and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). To enhance our understanding of the association between genotype and phenotype, we investigated a patient with mitochondrial encephalomyopathy and severe cerebral calcifications for a mtDNA mutation. There was a deletion of one of three T:A nucleotide pairs in the tRNALeu(UUR) gene of the mtDNA involving positions 3271 to 3273. Pedigree analysis suggested that this mutation may have occurred spontaneously in the proband. This analysis represents the smallest mtDNA deletion observed to date and is the first deletion identified within a mitochondrial tRNA. This observation emphasizes the importance of delineating the precise mutation responsible for an oxidative phosphorylation disease for patient diagnosis as well as for genetic counseling of maternal lineage relatives.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7854527     DOI: 10.1212/wnl.45.2.286

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Pitfalls in the diagnosis of mtDNA mutations.

Authors:  S Seneca; W Lissens; I Liebaers; P van den Bergh; M C Nassogne; A Benatar; L de Meirleir
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

Review 2.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

3.  Mutational analysis of whole mitochondrial DNA in patients with MELAS and MERRF diseases.

Authors:  Byung-Ok Choi; Jung Hee Hwang; Eun Min Cho; Eun Hye Jeong; Young Se Hyun; Hyeon Jeong Jeon; Ki Min Seong; Nam Soo Cho; Ki Wha Chung
Journal:  Exp Mol Med       Date:  2010-06-30       Impact factor: 8.718

4.  Maternal germ-line transmission of mutant mtDNAs from embryonic stem cell-derived chimeric mice.

Authors:  J E Sligh; S E Levy; K G Waymire; P Allard; D L Dillehay; S Nusinowitz; J R Heckenlively; G R MacGregor; D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

5.  1994 William Allan Award Address. Mitochondrial DNA variation in human evolution, degenerative disease, and aging.

Authors:  D C Wallace
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

6.  Retinal dystrophy associated with a single-base deletion mutation in mitochondrial DNA 3271 in patient with MELAS syndrome.

Authors:  Kenji Ozawa; Kiyofumi Mochizuki; Yusuke Manabe; Nobuaki Yoshikura; Takayoshi Shimohata; Ichizo Nishino; Yu-Ichi Goto
Journal:  Doc Ophthalmol       Date:  2019-01-30       Impact factor: 2.379

Review 7.  Insights Into the Role of Mitochondria in Vascular Calcification.

Authors:  Z L Zeng; Qing Yuan; Xuyu Zu; Jianghua Liu
Journal:  Front Cardiovasc Med       Date:  2022-04-29

8.  Analysis of mitochondrial DNA sequences in childhood encephalomyopathies reveals new disease-associated variants.

Authors:  Aijaz A Wani; Sajad H Ahanger; Sharmila A Bapat; Ashraf Y Rangrez; Nitin Hingankar; C G Suresh; Shama Barnabas; Milind S Patole; Yogesh S Shouche
Journal:  PLoS One       Date:  2007-09-26       Impact factor: 3.240

9.  De novo mtDNA point mutations are common and have a low recurrence risk.

Authors:  Suzanne C E H Sallevelt; Christine E M de Die-Smulders; Alexandra T M Hendrickx; Debby M E I Hellebrekers; Irenaeus F M de Coo; Charlotte L Alston; Charlotte Knowles; Robert W Taylor; Robert McFarland; Hubert J M Smeets
Journal:  J Med Genet       Date:  2016-07-22       Impact factor: 6.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.